Illawarra offshore wind zone declaration good news for…

Friends of the Earth Australia Media Release Today the federal government officially declared…

Why bet on a loser? Australia’s dangerous gamble…

By Michael Williss A fresh warning that the US will lose a war…

The Potential Labor Landslide...

I once wrote that the Liberals would be releasing their policies closer…

"Hungary is our Israel”: Tony Abbott and Orbán’s…

It was announced in late in 2023 that Tony Abbott was to…


By Bert Hetebry We are the mongrels Underneath the table, Fighting for the leavings Tearing us…

Diamonds and Cold Dust: Slaughter at Nuseirat

The ashes had barely settled on a Rafah tent camp incinerated by…

The EU Elections: The March of the Right

The EU elections over June 6 to June 9 have presented a…

Peter Dutton gutless and weak in not reducing…

Climate advocacy project Solutions for Climate Australia stated it was deeply disturbed…


Viral Optimism: The Pfizer-BioNTech Vaccine

The announcement that Pfizer Inc., along with its collaborative partner BioNTech SE, had come up with a successful vaccine candidate to combat the novel coronavirus SARS-CoV-2 sent the markets soaring. In New York, Pfizer’s shares rose by 15 per cent in pre-market trading; those of BioNTech, Nasdaq-listed, rose 25 per cent. “Today is a great day for science and humanity,” a confident Pfizer Chairman and CEO Albert Bourla crowed. “We are reaching this critical milestone in our vaccine development program at a time when the world needs it most with infection rates setting new records, hospitals nearing over-capacity and economies struggling to reopen.”

Bourla was in no mood to be modest about the record of the mRNA-based vaccine candidate, called BNT162b2. “With today’s news, we are a significant step closer to providing people around the world with a much needed breakthrough to help bring an end to this global health crisis. We look forward to sharing additional efficacy and safety data generated from thousands of participants in the coming weeks.”

The phase 3 clinical trial began on July 27, using 43,538 study participants. “The first interim analysis of our global Phase 3 study provides evidence that a vaccine may effectively prevent COVID-19,” explained Uğur Şahin of BioNTech, its co-founder and CEO. “This is a victory for innovation, science and a global collaborative effort.”

Bourla, perhaps realising that sceptics and the unsure will be eyeing such claims with reservation, has done much to squeeze the public relations process. In an open letter on October 16, he assumed a voice almost presidential in character. Forget elected officials or world leaders – here was Bourla as de facto vaccine president and humanitarian rescuer, “wanting to speak directly to the billions of people, millions of businesses, and hundreds of governments around the world that are investing their hopes in a safe and effective COVID-19 vaccine to overcome this pandemic.”

He promised transparency in the three areas where success had to be shown before approval for public use could be sought. The vaccine had to first be effective in preventing COVID-19 “in at least a majority of vaccinated persons.” It had to be demonstrated as safe “with robust safety data generated from thousands of patients.” It also had to be shown “that the vaccine can be consistently manufactured at the highest quality standards.”

Pfizer has also not exactly been transparent in releasing the full details of its preliminary analysis, but it certainly has been keen to celebrate the findings so far. The vaccine candidate, for instance, was “more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis.” Data was also drawn from 94 confirmed COVID-19 cases, though nothing has been said about the vaccine’s effectiveness on the issue of re-infection.

Of the enrolled participants, 42% had “diverse backgrounds” (“racially and ethnically”). No serious safety concerns were noted. Submission to the US Food and Drug Administration for Emergency Use Authorization is anticipated once “the required safety milestone is achieved.” The clinical trial is set to continue to its final analysis of 164 confirmed cases “to collect further data and characterize the vaccine candidate’s performance against other study endpoints.”

Such news, despite being based on interim data as yet unpublished in peer-review literature, delighted certain members of the scientific community. Sir John Bell, regius professor of medicine at Oxford University, could barely contain his excitement. “I am probably the first guy to say that [life will be back to normal by spring], but I will say that with some confidence.” Anthony Fauci of the US National Institutes of Health found the returns of the trial “just extraordinary”.

But even amidst the frothy enthusiasm, notes of caution gurgled. Erika Edwards for NBC News lists a few reservations. “Pfizer’s vaccine is a new type of technology that’s never been used in mass human vaccination before and experts caution that much remains unknown about its safety, how long it might work and who might benefit most.”

One such expert is Gregory Poland, director of the Mayo Clinic’s Vaccine Research Group in Rochester, Minnesota. “We don’t know anything about groups they didn’t study, like children, pregnant women, highly immunocompromised people and the eldest of the elderly.” Virologist Brenda Wren of the London School of Hygiene and Tropical Medicine is another. “It is a case of ‘so far so good’ but more confirmatory safety and efficacy studies are required.”

The heralded nature of the untried technological feature of the vaccine – at least when it comes to being applied to humans – lies in the speed and scale it can be manufactured at. Messenger-RNA (mRNA) tutors the immune system to target the spike protein of the virus. As Isabelle Bekeredjian-Ding of Germany’s Paul Ehrlich Institut describes it, “An mRNA is basically like a pre-form of a protein and its [sequence encodes] what the protein is basically made of later on.” Once delivered into the body, the cells read the mRNA as a set of instructions to build the viral protein in question. The molecules of the virus are thereby created but do not form the virus itself. The immune system, tricked as it were, picks up on the presence of such viral proteins, producing a defensive response.

Pfizer’s bubbly confidence will have to be read alongside its history of data manipulation and publication strategy, all in the service of profit maximisation. In 2008, it was found that Pfizer had tinkered with the publication of studies on the use of its epilepsy drug Neurontin, enabling it to sell the drug for uses not approved by the US Food and Drug Administration. Studies undertaken showing negative outcomes for the use of the drug for unapproved uses were suppressed or delayed.

In 2014, the company agreed to pay $325 million to resolve claims it defrauded insurers and health care benefit providers by marketing Neurontin for those unapproved uses. Despite forking out in the settlement, Pfizer refused to admit wrongdoing. Worth thinking about as more data from the BNT162b2 trials is gathered and released.


Like what we do at The AIMN?

You’ll like it even more knowing that your donation will help us to keep up the good fight.

Chuck in a few bucks and see just how far it goes!

Your contribution to help with the running costs of this site will be gratefully accepted.

You can donate through PayPal or credit card via the button below, or donate via bank transfer: BSB: 062500; A/c no: 10495969

Donate Button


Login here Register here
  1. josephus

    Not much use if immunity is short lived

  2. Ted

    An unproven technology designed to alter your genetic code means the end of your family gene lineage. Any children born after their parents get the mRNA vaccine may in effect become a genetic hybrid. This technology needs to be thoroughly questioned?
    Today, those under 70 years have a recovery rate from covid of over 95%, 5% better than those in the Pfizzer trial.
    Shakespeare had it right when he said of Big Pharma ‘A tale told by a group of idiots . . .’
    2020, Year of the Vaccine Cult, with clinics the new churches, doctors the high priests, and Big Pharma ‘god the daddy’.
    Fortunately, it is voluntary so only the true believers will partake.

  3. Wam

    Too dodgy to be trusted!
    You have to scream at the “I have done nothing wrong, brigade”. The trump did nothing whilst 10m people got the virus and 230000 died so he can say he did nothing wrong.
    Old cynics are very wary of big septic multinationals but if trump is right that Pfizer delayed the announcement so trump wouldn’t get the credit then maybe Boulia on his $18m salary is a Democrat??

    /&*3@& big money, Ted, when public money is available the pigs will kill to get to the trough first.

  4. Ted

    True Wam. Never before in history has a virus been a political candidate.
    We are being gamed by politicians with agendas and Big Pharma with one interest – profits.
    As far as the stats and the science of false positives goes, check this out if you have time (23 mins):
    Covid testing fraud
    I am over the lack of scientific method being shown by the medical industry.
    The alternative view of things is worse, they are deliberately misleading the public.

  5. Jo.

    Here we go again. Ted (or perhaps it’s even Del) – you must do better with your links.

    Del Matthew Bigtree is an American television and film producer and the CEO of the anti-vaccination group Informed Consent Action Network, which produced the film Vaxxed: From Cover-Up to Catastrophe, based on the discredited[1][2][3] views of Andrew Wakefield on an alleged connection between vaccines and autism. Despite having no medical training,[4] Bigtree has appeal as a public speaker, and a recent influx of funding[5] has made him one of the most prominent voices in the anti-vaccination movement.

    During the COVID-19 pandemic, Bigtree propagated baseless conspiracy theories about the origin of the virus and urged his audience to ignore the advice of health authorities

    Indeed – much, much better! And you might wonder how Trump was elected. Enormous demand for a vaccine again anti-vaxxers because they are in plague proportions.

  6. Ted

    Jo, great example of time management, you watched a 23 minute video, researched an article in wikipedia, cut & pasted a passage and added in your thoughts in 16 minutes. Del, or anyone for that matter, doesn’t need to be a doctor to interview one nor does he need to be a doctor to make a public comment. For the books, I’m not and anti-vaxxer, I think the term is vaccine reluctant.
    The link was for Wam btw, you didn’t need to check it if you are totally confident with the current narrative.

  7. Jo.

    Ted – been around long enough to check the credibility or otherwise of sources before potentially wasting time viewing, reading or listening to what might be the latest nonsense from quacks. It goes with the critical consciousness territory. You should try it. Sorry Ted but now you have a reputation and it’s been entirely of your own making.

    This is a blog. If you want to have private exchanges, then get a room.

    As they say :- By their sources – you shall know them.

  8. Brozza

    A press release from big pharma, (look at u$, ka-ching, aren’t we great), NOT a peer reviewed paper.

  9. king1394

    We have been softened up to believe the magic of vaccination will save the world. Yes, many illnesses have been controlled through vaccinations, which have been long trialled and tested, though still in some cases found somewhat wanting. The history of vaccination has some unethical human experimentation underlying the modern vaccines we have come to know and trust. Pasteur and the little village boy who was vaccinated and then exposed to rabies springs to mind.

    This rush to market with anything that appears to work in the short term, requires more trust than I, for one, am willing to extend.

Leave a Reply

Your email address will not be published. Required fields are marked *

The maximum upload file size: 2 MB. You can upload: image, audio, video, document, spreadsheet, interactive, text, archive, code, other. Links to YouTube, Facebook, Twitter and other services inserted in the comment text will be automatically embedded. Drop file here

Return to home page